Cargando…
No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
PURPOSE: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541531/ https://www.ncbi.nlm.nih.gov/pubmed/37328621 http://dx.doi.org/10.1007/s00259-023-06293-2 |
_version_ | 1785113921432059904 |
---|---|
author | Schiebler, Tassilo Apostolova, Ivayla Mathies, Franziska Lara Lange, Catharina Klutmann, Susanne Buchert, Ralph |
author_facet | Schiebler, Tassilo Apostolova, Ivayla Mathies, Franziska Lara Lange, Catharina Klutmann, Susanne Buchert, Ralph |
author_sort | Schiebler, Tassilo |
collection | PubMed |
description | PURPOSE: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysis of DAT-SPECT in a large patient sample. METHODS: One thousand seven hundred forty consecutive DAT-SPECT with (123)I-FP-CIT from clinical routine were included retrospectively. SPECT images were reconstructed iteratively without and with ASC. Attenuation correction was based on uniform attenuation maps, scatter correction on simulation. All SPECT images were categorized with respect to the presence versus the absence of Parkinson-typical reduction of striatal (123)I-FP-CIT uptake by three independent readers. Image reading was performed twice to assess intra-reader variability. The specific (123)I-FP-CIT binding ratio (SBR) was used for automatic categorization, separately with and without ASC. RESULTS: The mean proportion of cases with discrepant categorization by the same reader between the two reading sessions was practically the same without and with ASC, about 2.2%. The proportion of DAT-SPECT with discrepant categorization without versus with ASC by the same reader was 1.66% ± 0.50% (1.09–1.95%), not exceeding the benchmark of 2.2% from intra-reader variability. This also applied to automatic categorization of the DAT-SPECT images based on the putamen SBR (1.78% discrepant cases between without versus with ASC). CONCLUSION: Given the large sample size, the current findings provide strong evidence against a relevant impact of ASC with uniform attenuation and simulation-based scatter correction on the clinical utility of DAT-SPECT to detect nigrostriatal degeneration in patients with clinically uncertain parkinsonian syndrome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06293-2. |
format | Online Article Text |
id | pubmed-10541531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105415312023-10-02 No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome Schiebler, Tassilo Apostolova, Ivayla Mathies, Franziska Lara Lange, Catharina Klutmann, Susanne Buchert, Ralph Eur J Nucl Med Mol Imaging Original Article PURPOSE: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysis of DAT-SPECT in a large patient sample. METHODS: One thousand seven hundred forty consecutive DAT-SPECT with (123)I-FP-CIT from clinical routine were included retrospectively. SPECT images were reconstructed iteratively without and with ASC. Attenuation correction was based on uniform attenuation maps, scatter correction on simulation. All SPECT images were categorized with respect to the presence versus the absence of Parkinson-typical reduction of striatal (123)I-FP-CIT uptake by three independent readers. Image reading was performed twice to assess intra-reader variability. The specific (123)I-FP-CIT binding ratio (SBR) was used for automatic categorization, separately with and without ASC. RESULTS: The mean proportion of cases with discrepant categorization by the same reader between the two reading sessions was practically the same without and with ASC, about 2.2%. The proportion of DAT-SPECT with discrepant categorization without versus with ASC by the same reader was 1.66% ± 0.50% (1.09–1.95%), not exceeding the benchmark of 2.2% from intra-reader variability. This also applied to automatic categorization of the DAT-SPECT images based on the putamen SBR (1.78% discrepant cases between without versus with ASC). CONCLUSION: Given the large sample size, the current findings provide strong evidence against a relevant impact of ASC with uniform attenuation and simulation-based scatter correction on the clinical utility of DAT-SPECT to detect nigrostriatal degeneration in patients with clinically uncertain parkinsonian syndrome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06293-2. Springer Berlin Heidelberg 2023-06-17 2023 /pmc/articles/PMC10541531/ /pubmed/37328621 http://dx.doi.org/10.1007/s00259-023-06293-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Schiebler, Tassilo Apostolova, Ivayla Mathies, Franziska Lara Lange, Catharina Klutmann, Susanne Buchert, Ralph No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome |
title | No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome |
title_full | No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome |
title_fullStr | No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome |
title_full_unstemmed | No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome |
title_short | No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome |
title_sort | no impact of attenuation and scatter correction on the interpretation of dopamine transporter spect in patients with clinically uncertain parkinsonian syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541531/ https://www.ncbi.nlm.nih.gov/pubmed/37328621 http://dx.doi.org/10.1007/s00259-023-06293-2 |
work_keys_str_mv | AT schieblertassilo noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome AT apostolovaivayla noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome AT mathiesfranziskalara noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome AT langecatharina noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome AT klutmannsusanne noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome AT buchertralph noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome |